Contract Interpretation. This Agreement is the joint product of each Investor and the Company and each provision hereof has been subject to the mutual consultation, negotiation and agreement of such parties and shall not be construed for or against any party hereto.
Appears in 146 contracts
Sources: Registration Rights Agreement (First Tracks Biotherapeutics, Inc.), Securities Purchase Agreement (First Tracks Biotherapeutics, Inc.), Registration Rights Agreement (Alaunos Therapeutics, Inc.)
Contract Interpretation. This Agreement is the joint product of each Investor and the Company and each provision hereof of this Agreement has been subject to the mutual consultation, negotiation and agreement of such parties and shall not be construed for or against any party hereto.
Appears in 107 contracts
Sources: Securities Purchase Agreement (First Tracks Biotherapeutics, Inc.), Securities Purchase Agreement (Telomir Pharmaceuticals, Inc.), Securities Purchase Agreement (Chemomab Therapeutics Ltd.)
Contract Interpretation. This Agreement is the joint product of each the Investor and the Company and each provision hereof has been subject to the mutual consultation, negotiation and agreement of such parties and shall not be construed for or against any party hereto.
Appears in 10 contracts
Sources: Registration Rights Agreement (Summit Therapeutics Inc.), Registration Rights Agreement (Karyopharm Therapeutics Inc.), Registration Rights Agreement (Karyopharm Therapeutics Inc.)
Contract Interpretation. This Agreement is the joint product of each the Investor and the Company and each provision hereof of this Agreement has been subject to the mutual consultation, negotiation and agreement of such parties and shall not be construed for or against any party hereto.
Appears in 9 contracts
Sources: Securities Purchase Agreement (Diginex LTD), Securities Purchase Agreement (Diginex LTD), Securities Purchase Agreement (Diginex LTD)
Contract Interpretation. This Agreement is the joint product of each Investor Purchaser and the Company and each provision hereof has been subject to the mutual consultation, negotiation and agreement of such parties and shall not be construed for or against any party hereto.
Appears in 6 contracts
Sources: Registration Rights Agreement (Rallybio Corp), Subscription Agreement (Rallybio Corp), Registration Rights Agreement (Summit Therapeutics Inc.)
Contract Interpretation. This Agreement is the joint product of each Investor and the Company Company, and each provision hereof of this Agreement has been subject to the mutual consultation, negotiation and agreement of such parties and shall not be construed for or against any party hereto.
Appears in 4 contracts
Sources: Securities Purchase Agreement (Mama's Creations, Inc.), Securities Purchase Agreement (Processa Pharmaceuticals, Inc.), Securities Purchase Agreement (180 Life Sciences Corp.)
Contract Interpretation. This Agreement is the joint product of each Investor the Purchaser and the Company and each provision hereof of this Agreement has been subject to the mutual consultation, negotiation and agreement of such parties and shall not be construed for or against any party hereto.
Appears in 4 contracts
Sources: Securities Purchase Agreement (Rein Therapeutics, Inc.), Securities Purchase Agreement (Rein Therapeutics, Inc.), Securities Purchase Agreement (Athira Pharma, Inc.)
Contract Interpretation. This Agreement is the joint product of each Investor and the Company Company, and each provision hereof has been subject to the mutual consultation, negotiation and agreement of such parties and shall not be construed for or against any party hereto.
Appears in 3 contracts
Sources: Registration Rights Agreement (Jade Biosciences, Inc.), Registration Rights Agreement (Jade Biosciences, Inc.), Registration Rights Agreement (SolarWindow Technologies, Inc.)
Contract Interpretation. This Agreement is the joint product of each Investor the Investors and the Company and each provision hereof of this Agreement has been subject to the mutual consultation, negotiation and agreement of such parties and shall not be construed for or against any party hereto.
Appears in 3 contracts
Sources: Note Purchase Agreement (Vroom, Inc.), Note Purchase Agreement (Vroom, Inc.), Securities Purchase Agreement (ProMIS Neurosciences Inc.)
Contract Interpretation. This Agreement is the joint product of each Investor the Holder and the Company and each provision hereof has been subject to the mutual consultation, negotiation and agreement of such parties and shall not be construed for or against any party hereto.
Appears in 2 contracts
Sources: Registration Rights Agreement (Bitgo Holdings, Inc.), Registration Rights Agreement (SAIHEAT LTD)
Contract Interpretation. This Agreement is the joint product of each Investor the Buyer and the Company and each provision hereof of this Agreement has been subject to the mutual consultation, negotiation and agreement of such parties and shall not be construed for or against any party hereto.
Appears in 2 contracts
Sources: Equity Purchase Agreement (Skye Bioscience, Inc.), Equity Purchase Agreement (Skye Bioscience, Inc.)
Contract Interpretation. This Agreement is the joint product of each Investor the Buyer and the Company and each provision hereof has been subject to the mutual consultation, negotiation and agreement of such parties and shall not be construed for or against any party hereto.
Appears in 2 contracts
Sources: Equity Purchase Agreement (Skye Bioscience, Inc.), Equity Purchase Agreement (Skye Bioscience, Inc.)
Contract Interpretation. This Agreement is the joint product of each Investor and the Company and each provision hereof of this Agreement has been subject to the mutual consultation, negotiation and agreement of such parties and shall not be construed for or against any party hereto.
Appears in 2 contracts
Sources: Warrant Purchase Agreement (XCF Global, Inc.), Warrant Purchase Agreement (XCF Global, Inc.)
Contract Interpretation. This Agreement is the joint product of each Investor the Purchaser and the Company and each provision hereof has been subject to the mutual consultation, negotiation and agreement of such parties and shall not be construed for or against any either party hereto.
Appears in 2 contracts
Sources: Registration Rights Agreement (Athira Pharma, Inc.), Registration Rights Agreement (Athira Pharma, Inc.)
Contract Interpretation. This Agreement is the joint product of each Investor Purchaser and the Company and each provision hereof of this Agreement has been subject to the mutual consultation, negotiation and agreement of such parties and shall not be construed for or against any party hereto.
Appears in 2 contracts
Sources: Subscription Agreement (Rallybio Corp), Subscription Agreement (Rallybio Corp)
Contract Interpretation. This Agreement is the joint product of each Investor the Investor, the Selling Shareholder and the Company Company, and each provision hereof of this Agreement has been subject to the mutual consultation, negotiation and agreement of such parties and shall not be construed for or against any party hereto.
Appears in 1 contract
Contract Interpretation. This Agreement is the joint product of each Investor Holder and the Company and each provision hereof has been subject to the mutual consultation, negotiation and agreement of such parties and shall not be construed for or against any party hereto.
Appears in 1 contract
Sources: Registration Rights Agreement (ChargePoint Holdings, Inc.)
Contract Interpretation. This Agreement is the joint product of each Investor and the Company and Investor, and each provision hereof of this Agreement has been subject to the mutual consultation, negotiation and agreement of such parties and shall not be construed for or against any party the parties hereto.
Appears in 1 contract
Contract Interpretation. This Agreement is the joint product of each Investor and the Company and each provision hereof has been subject to the mutual consultation, negotiation and agreement of such parties and shall not be construed for or against any party hereto.. 13No
Appears in 1 contract
Contract Interpretation. This Agreement is the joint product of each Investor and the Company and each provision hereof has been subject to the mutual consultation, negotiation and agreement of such parties Parties and shall not be construed for or against any party heretoParty.
Appears in 1 contract
Sources: Registration Rights Agreement (Hycroft Mining Holding Corp)
Contract Interpretation. This Agreement is the joint product of each Investor and the Company Issuer and each provision hereof has been subject to the mutual consultation, negotiation and agreement of such parties and shall not be construed for or against any party hereto.
Appears in 1 contract
Sources: Registration Rights Agreement (Senti Biosciences, Inc.)
Contract Interpretation. This Agreement is the joint product of each Investor and the Company and each provision hereof has been subject to the mutual consultation, β negotiation and agreement of such parties and shall not be construed for or against any party hereto.
Appears in 1 contract
Sources: Registration Rights Agreement (Dogwood Therapeutics, Inc.)
Contract Interpretation. This Agreement is the joint product of each Investor and the Company and each provision hereof of this Agreement has been subject to the mutual consultation, negotiation and agreement of such parties and shall not be construed for or against any party hereto.. 8.17
Appears in 1 contract
Sources: Securities Purchase Agreement (AEON Biopharma, Inc.)
Contract Interpretation. This Agreement is the joint product of each Investor and the Company Company, and each provision hereof has been subject to the mutual consultation, negotiation negotiation, and agreement of such parties and shall not be construed for or against any party hereto.
Appears in 1 contract
Sources: Registration Rights Agreement (Mama's Creations, Inc.)
Contract Interpretation. This Agreement is the joint product of each Investor the Purchaser and the Company and each provision hereof has been subject to the mutual consultation, negotiation and agreement of such parties and shall not be construed for or against any party hereto.
Appears in 1 contract
Contract Interpretation. This Agreement is the joint product of each Investor the Investors, the Collateral Agent and the Company and each provision hereof of this Agreement has been subject to the mutual consultation, negotiation and agreement of such parties and shall not be construed for or against any party hereto.
Appears in 1 contract
Contract Interpretation. This Agreement is the joint product of each Investor Shareholder and the Company and each provision hereof has been subject to the mutual consultation, negotiation and agreement of such parties and shall not be construed for or against any party hereto.
Appears in 1 contract
Sources: Registration Rights Agreement (Epsilon Energy Ltd.)
Contract Interpretation. This Agreement is the joint product of each Investor Seller and the Company Purchaser and each provision hereof has been subject to the mutual consultation, negotiation and agreement of such parties and shall not be construed for or against any party hereto.
Appears in 1 contract
Contract Interpretation. This Agreement is the joint product of each the Investor and the Company Company, and each provision hereof has been subject to the mutual consultation, negotiation and agreement of such parties and shall not be construed for or against any party hereto.
Appears in 1 contract